Charles A. Rowland Jr. - 19 Sep 2022 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role: Director
Signature: /s/ Jennifer Elliott, Attorney-in-Fact
Issuer symbol: GBIO
Transactions as of: 19 Sep 2022
Net transactions value: +$82,845
Form type: 4
Filing time: 20 Sep 2022, 16:16:45 UTC
Previous filing: 19 Sep 2022
Next filing: 04 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GBIO	Common Stock	Purchase	$82,845	+15,750	+8.9%	$5.26	191,797	19 Sep 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.14 to $5.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.14 to $5.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.